Company Filing History:
Years Active: 2013
Title: Eric Lacazette: Innovator in Angiogenesis Research
Introduction
Eric Lacazette is a prominent inventor based in Toulouse, France. He has made significant contributions to the field of medical research, particularly in the area of angiogenesis. His work focuses on developing innovative solutions for treating various pathologies.
Latest Patents
Eric Lacazette holds a patent for "Neutralizing antibodies and fragments thereof directed against platelet factor-4 variant 1 (PF4V1)." This invention relates to neutralizing antibodies and fragments that target Platelet Factor-4 variant 1 (PF4v1). The patent outlines their potential use in treating conditions that require the induction of angiogenesis or diseases associated with pathological angiogenesis. He has 1 patent to his name.
Career Highlights
Lacazette is affiliated with the Institut National de la Santé et de la Recherche Médicale, where he conducts his research. His work has been instrumental in advancing the understanding of angiogenesis and its implications in various medical conditions.
Collaborations
He has collaborated with notable researchers, including Andreas Bikfalvi and Alexandre Dubrac, to further enhance the impact of his work in the field.
Conclusion
Eric Lacazette's innovative research and patent contributions are paving the way for new treatments in angiogenesis-related diseases. His dedication to medical science continues to inspire advancements in healthcare.